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Abstract The oxidation of low density lipoprotein (LDL) in the 
arterial wall may contribute to atherogenesis. The oxidation of 
LDL by cells usually requires catalytically active transition metal 
ions. We show here some that gruel samples from human ad- 
vanced atherosclerotic lesions are capable of catalysing the oxi- 
dation of LDL by macrophages as measured by thiobarbituric 
acid-reactive substances, enhanced electrophoretic mobility and 
increased macrophage uptake. This catalysis could be inhibited 
by pretreatment of the gruel with Chelex-100, which binds transi- 
tion metal ions. The presence of catalytically active transition 
metal ions in atherosclerotic lesions may help to explain why 
LDL oxidation occurs at these sites. 
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1. Introduction 
confirmed by Swain and Gutteridge [18], who also showed that 
lesions can contain ferrioxidase I activity, due to caeruloplas- 
min, and immunologically-detectable caeruloplasmin. Ferroxi- 
dase 3 activity, due to xanthine oxidase, was also present in 
some lesions. Homogenates of some lesions, but not all, could 
stimulate the oxidation of linoleic acid micelles in the presence 
of ascorbate [18]. In addition, catalytically active iron and cop- 
per have been shown to be present in mechanically disrupted 
early lesions and the normal arterial wall [19]. We have demon- 
strated here that gruel from atherosclerotic lesions is capable 
of catalysing the oxidation of LDL by macrophages and that 
this catalytic activity is due to the presence of transition metal 
ions. 
2. Materials and methods 
2.1. Reagents 
All reagents and media were treated with Chelex-100 (Sigma, Poole, 
Dorset, UK) prior to use, to remove any contaminating transition metal 
ions. 
The local oxidation of low density lipoprotein (LDL) in the 
arterial wall may result in its increased uptake by macrophages 
and foam cell formation. Oxidised LDL may also play other 
roles in atherogenesis, including increasing the migration of 
monocytes into the arterial wall and cytotoxicity [1,2]. 
The mechanisms by which LDL becomes oxidised in the 
arterial wall remain uncertain. It has been demonstrated in
vitro, however, that LDL can be oxidised by the main cells 
present in atherosclerotic lesions, namely endothelial cells [3], 
smooth muscle cells [4], monocyte-macrophages [5 7] and lym- 
phocytes [8]. Most workers find that LDL oxidation by cells 
requires the presence of transition metal ions, usually iron [7,9], 
but copper ions will also catalyse the oxidation [9,10]. A suffi- 
ciently high concentration of iron [7,9] or copper [10,11] can 
catalyse the oxidation of LDL in the absence of cells. 
Free iron and copper ions capable of catalysing free radical 
reactions are not normally found in the plasma, but are firmly 
bound to proteins, namely transferrin and ferritin for iron [12- 
14] and caeruloplasmin for copper [15,16]. It has been demon- 
strated by Smith et al. [17], however, that gruel extracted from 
advanced atherosclerotic lesions from human aortas can con- 
tain significant amounts of catalytically active copper (0-28 
/IM) or iron ions (0-7/IM). This finding has very recently been 
*Corresponding author. Fax: (44) (1734) 31 0180. 
Abbreviations: BHT, butylated hydroxytoluene; DMEM, Dulbecco's 
modified Eagle's medium; LDL, low density lipoprotein; MDA, malon- 
dialdehyde; TBARS, thiobarbituric a id-reactive substances. 
2.2. Isolation and radioiodination fLDL 
LDL (1.019 1.063 g/ml) was isolated from normal pooled human 
plasma by sequential density ultracentrifugation n KBr solutions at 
4°C as described elsewhere [20] and radiolabelled with Na125I using 
iodine monochloride [7]. 
2.3. Gruel extraction 
Gruel was extracted from advanced atherosclerotic lesions in the 
abdominal orta of cadavers within 8 125 h after death by washing the 
artery with water to remove blood, then incising the lesion with a scalpel 
and scraping out the yellow semi-solid gruel with the blunt edge of the 
scalpel. Pooled gruel from several lesions in the same aorta was frozen 
at -70°C. Storage at -70°C did not exceed 1 month which, normally 
does not result in oxidative deterioration of biological samples [21]. 
2.4. Oxidation of LDL by macrophages 
Known masses of gruel (0.26g + 0.12; mean + S.D.) were homogen- 
ised in a Potter homogeniser in 4.8 ml of Ham's F-10 medium (ICN 
Flow, Thame, Oxfordshire, UK) specially formulated to be deficient in 
FeSO4, CuSO4, ZnSO4 and L-cysteine (the absence of detectable 
amounts of Fe and Cu in the Ham's F-10 medium was confirmed by 
us by atomic absorption spectroscopy). Half of the homogenate (and 
also Ham's F-10 medium containing either 1 /tM CuSO4 or 6 ,uM 
FeSO4) was treated with 0.8 g Chelex-100 for 1 h, the remaining half 
being untreated. Each was centrifuged at 1500 ×g for 1 h at 4°C and 
the supernatant was removed. 
Resident mouse peritoneal macrophages were isolated by peritoneal 
lavage of female Swiss T.O. mice as described elsewhere [7]. 125I-La- 
belled LDL (100 jig protein/ml) was incubated at 37°C under 5% CO 2 
in air in triplicate with intact macrophages (1.0 × 10 6 peritoneal cells/ 
well) or in cell-free wells with 0.4 ml per well of the gruel supernatants 
containing 100/IM cystine. The purpose of adding the cystine was to 
allow the macrophages to take it up, reduce it to cysteine and release 
this into the medium, thereby promoting the oxidation of LDL in the 
wells containing cells [22,23] but not in the wells without cells. The 
oxidation of LDL was stopped after 18 h with 20 pM butylated hy- 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSD10014-5793(95)01068-8 
D.J. Lamb et al./FEBS Letters 374 (1995) 12-16 13 
droxytoluene (BHT; from a stock solution of 2 mM in ethanol) and 
1 mM EDTA. 
215. Determination of oxidised LDL degradation by a J774 
macrophage-like c ll line 
Oxidised or control ~25I-labelled LDL was diluted to 10/.tg protein/ml 
in DMEM containing 20% (v/v) foetal calf serum, 10 IU penicillin/ml, 
10/tg streptomycin/ml and 5 pg amphotericin B/ml (Gibco, Uxbridge, 
Middlesex, UK). It was then incubated for 20-22 h with J774 cells, a 
macrophage-like c ll-line, (0.2 x 106 cells/well) or cell-free wells at 1 ml 
per well. The radioactive noniodide, trichloroacetic a id-soluble degra- 
dation products released into the medium were measured as described 
previously [19]. The degradation products in the cell-free wells were 
subtracted from those in the wells containing cells. The cells were 
washed in PBS containing Ca 2+ and Mg z+, and lysed in 2 ml of 0.2 M 
NaOH as described elsewhere [7]. The lysate was assayed for protein 
by a modified Lowry procedure [24] and the radioactivity determined 
as a measure of cell-associated LDL. This cell-associated radioactivity 
was added to the degradation products in the medium as a measure of 
total tzsI-labelled LDL uptake. 
2.6. Thiobarbituric acid-reactive substances (TBARS) assay 
Samples (100/ll) of oxidised and control LDL and standards of 
tetramethoxypropane were taken in triplicate and to each was added 
1 ml of 0.335% (w/v) thiobarbituric acid in 10% (w/v) trichloroacetic 
acid [25]. They were heated at 95°C for 15 min, centrifuged at 1500 x g 
for 5 min at 4°C, and the absorbance measured at 535 nm. The results 
were expressed as nmol of malondialdehyde (MDA) equivalents per mg 
of LDL protein. 
2. 7 Determination of LDL electrophoretic mobility 
Samples (5/tl) were loaded on to a Beckman Paragon agarose gel and 
electrophoresed at 100 V for 30 min, fixed, dried and stained with the 
lipid stain Sudan Black. The distance of LDL migration was then 
measured to the centre of the band. 
3. Results 
1251-Labelled LDL was incubated with mouse peritoneal 
macrophages or in cell-free wells in the presence of homogeni-  
sed gruel supernatants in Ham's  F-10 medium deficient in iron 
and copper ions. The TBARS generated, the electrophoretic 
mobil ity of the LDLs and the rate of uptake of these LDLs by 
a macrophage-l ike c ll line 0774) were then determined. 
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Fig. 1. The effect of complete or centrifuged gruel homogenate on LDL 
oxidation by macrophages. IzSI-Labelled LDL (100/lg protein/ml) was 
incubated for 18 h with complete gruel homogenate or a supernatant 
of gruel homogenate in the presence (macrophage) or absence (control) 
of macrophages. The rate of uptake of these LDLs by the macrophage- 
like cell-line J774 was then determined. Each bar is the mean + S.E.M. 
of three wells. These results are representative of 2 independent exper- 
iments. 
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Fig. 2. The effect of treating ruel from human atherosclerotic lesions 
with Chelex- 100 on LDL oxidation by macrophages. ~25I-Labelled LDL 
(100/~g protein/ml) was incubated with gruel supernatants (Me, CON) 
or Chelex-100 treated gruel supernatants (M0-Chelex, CON-Chelex) in 
the presence (Me, M¢-Chelex) or absence (CON, CON-Chelex) of 
macrophages for 18 h. The TBARS generated from these LDLs were 
then determined, including TBARS in gruel samples alone (GRUEL). 
Each bar is the mean + S.E.M. of three wells. The electrophoretic 
mobility of these LDLs was also determined and expressed as the 
percentage migration compared to native LDL migration. The rate of 
uptake of these LDLs by a J774 macrophage-like c ll line was also 
determined. Each bar is the mean + S.E.M. of three wells. 
The result of centrifugation of the gruel homogenates was a 
large pellet of gruel debris and a buoyant  layer of lipid. The 
supernatant was taken so as not to disturb either the pellet or 
lipid layer. Fig. 1 shows the effect of incubating either complete 
gruel homogenate or a supernatant of gruel homogenate with 
macrophages or in cell-free wells on the oxidation of LDL as 
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Fig. 3. The effect of Chelex-100 treatment of Ham's F-10 medium 
containing either copper or iron ions on LDL oxidation by macro- 
phages. ~25-Labelled LDL (100 pg protein/ml)was incubated in Ham's 
F-10 medium (specially formulated to be deficient in CuSO4 and FeSO4) 
containing either 1 /IM CuSO4 or 6 pM FeSO4 (Mq~, CON) or in 
Chelex-100 treated Ham's F-10 medium (M0-Chelex, CON-Chelex) in 
the presence (M0, M¢-Chelex) or absence (CON, CON-Chelex) of 
macrophages for 18 h. The TBARS and the rate of uptake of these 
LDLs by the macrophage-like cell line J774 were then determined. Each 
bar is the mean + S.E.M. of three wells. The TBARS in the Chelex-100 
pretreated Ham's F-10 medium containing control LDL and FeSO4 
were too low to measure. These results are representative of 3 independ- 
ent experiments. 
determined by macrophage uptake. There was no great differ- 
ence between incubating with a complete homogenate or a 
homogenate supernatant on the oxidation of the LDL by mac- 
rophages. The remaining experiments were therefore con- 
ducted with supernatants of gruel homogenates to avoid having 
the large particles of debris or the floating lipids present. 
Table 1 shows the macrophage uptake of macrophage-mod- 
ified LDL and cell-free control LDL that had been incubated 
with homogenised gruel supernatants, and also the macrophage 
uptake of native LDL which had not been previously incu- 
bated. Of the 19 gruel samples that had been incubated with 
LDL in the presence or absence of macrophages, 13 supported 
a statistically significant increase in the uptake of the LDL by 
macrophages compared to the uptake of the native LDL. Incu- 
bation of the gruel and LDL with macrophages resulted in a 
statistically significant increase in the uptake of LDL compared 
to the LDL that had been incubated in cell-free wells in 7 of 
the 19 samples. 
The 19 samples of gruel were examined in 5 experiments 
which yielded similar results, although the absolute rate of 
uptake of the native, control and macrophage-modified LDL 
varied considerably between experiments probably because of 
variations in the endocytic activity or receptor expression of the 
J774 'target' macrophage cultures. Fig. 2 shows the TBARS, 
relative electrophoretic mobility and macrophage uptake data 
from one of these experiments. One sample (P94 886) stimu- 
lated oxidation of the LDL in the presence of macrophages so 
that over 100 nmol TBARS/mg LDL protein were generated 
over and above the TBARS already present in the gruel sample. 
This oxidation also resulted in the LDL migrating 2.5 times 
faster on an agarose gel than the native LDL and in a doubling 
in its rate of uptake by 'target' macrophages. This oxidation, 
measured by all three parameters, was much less in the absence 
of macrophages and was inhibited by pretreatment of the gruel 
by Chelex-100 both in the presence and absence of macro- 
phages. Another sample (P94 856) stimulated oxidation mod- 
estly in the presence of macrophages as measured by all three 
parameters. There was no oxidation in the absence ofmacroph- 
ages, and the macrophage-mediated oxidation was again inhib- 
ited by pretreatment of the gruel with Chelex-100. Some gruel 
samples (e.g. P94 534 and P94 832) appeared to stimulate little 
or no oxidation in the presence or absence of macrophages as 
measured by TBARS, although there appeared to be a marginal 
increase in electrophoretic mobility for all conditions for gruel 
P94 534 compared to the native (non-incubated) LDL. There 
was an increase in macrophage uptake compared to native 
LDL for both gruel samples, although there was little difference 
between macrophage-modified and control LDL (Table 1). 
Table l 
The effect of gruel samples from human atherosclerotic lesions on LDL 
oxidation by macrophages 
Gruel sample Macrophage uptake (fig LDL protein/rag cell protein 
in 18 h) 
Macrophage- Control Native 
modified 
P92 662 0.130 + 0.018" 0.031 + 0.012 0.036 + 0.021 
P92 664 0.279 + 0.044* 0.197 + 0.026* 0.036 + 0.021 
P92 684 0.093 + 0.006* 0.067 + 0.006 0.045 + 0.009 
P92 744 0.074 + 0.002 0.040 + 0.002 0.045 + 0.009 
P92 749 0.104 + 0.014" 0.096 + 0.016 0.045 _+ 0.009 
P92 773 0.043 + 0.006 0.065 + 0.015 0.045 + 0.009 
P92 774 0.085 + 0.008* 0.081 + 0.006* 0.045 + 0.009 
P92 790 0.149 + 0.012" 0.092 + 0.013 0.045 + 0.009 
P94 779 1.097 + 0.121" 0.404 + 0.051 0.263 + 0.006 
P94 798 0.152 + 0.018 0.182 + 0.006 0.263 + 0.006 
P94 534 0.266 _+ 0.037* 0.271 + 0.042 0.229 + 0.029 
P94 832 0.246 _+ 0.039 0.302 + 0.015 0.229 + 0.029 
P94 856 0.296 + 0.033* 0.197 _+ 0.012 0.229 + 0.029 
P94 886 0.477 + 0.059 0.259 + 0.042 0.229 + 0.029 
P95 248 0.628 + 0.004* 0.234 _+ 0.031 0.211 + 0.024 
P95 290 0.490 _+ 0.033* 0.210 _+ 0.015 0.211 _+ 0.024 
P95 400 0.302 + 0.034 0.242 + 0.011 0.211 + 0.024 
P95 473 0.906 + 0.133" 0.445 _+ 0.031" 0.211 + 0.024 
P95 474 0.642 + 0.025* 0.511 + 0.051" 0.211 _+ 0.024 
t25I-Labelled LDL (100 pg protein/ml) was incubated with gruel super- 
natants in the presence (macropfiage-modified) or absence (control) of 
macrophages for 18 h. The rate of uptake of macrophage-modified, 
control and native (non-incubated) LDLs by the macrophage-like c ll 
line J774 was then determined. Each entry is the mean _+ S.E.M. of 
three wells. 
*Denotes a statistically significant increase in uptake compared with 
the native LDL (P < 0.05). 
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These increases are unlikely to be due to oxidation because of 
the lack of increase of TBARS, but more likely a direct result 
of an interaction of the LDL with one of the many components 
of the gruel. 
Fig. 3 shows that Chelex-100 treatment was effective in re- 
moving copper or iron ions from Ham's F-10 medium. Macro- 
phages oxidised LDL well in Ham's F-10 medium specially 
formulated to be deficient in FeSO 4 or CuSO 4 to which either 
1/2M CuSO4 or 6/2M FeSO4 had been added, as measured by 
either TBARS or enhanced macrophage uptake. There was also 
a modest increase in TBARS in the presence of 1/~M CuSO4 
alone, although this was insufficient to modify the apolipopro- 
tein B-100 enough to result in increased uptake by macro- 
phages, an event that occurs later than the rise in TBARS. 
Oxidation of LDL in the presence of absence of macrophages 
was inhibited by pretreatment of the CuSO4 or FeSO4 contain- 
ing Ham's F-10 medium with Chelex-100. 
4. Discussion 
Our results show that the gruel from human advanced 
atherosclerotic plaques is capable of modifying LDL resulting 
in its increased uptake by macrophages. By centrifuging the 
gruel homogenates and using the supernatants below the float- 
ing lipid layer, we were able to show that the modification of 
LDL by macrophages was not mediated by either the large 
particulate content of the gruel or by the lipid content hat 
floated upon low-speed centrifugation. 
The modification of LDL sometimes occurred both in the 
presence and absence of 'modifying' macrophages and to a 
similar degree in both (for example P92 749 and P95 474). 
Because the 'modifying' macrophages were unable to enhance 
the degree of LDL modification i such cases, it is unlikely that 
this modification was oxidative and probably resulted from a 
direct interaction between the LDL and the gruel contents. 
Hoff and O'Neil [26] showed that the contents of atheroscle- 
rotic plaques were capable of modifying LDL so that it was 
taken up faster by macrophages, but were unable to show that 
this modification was oxidative. 
Other gruel samples (for example P94 856 or P94 886) cata- 
lysed macrophage-mediated LDL modification so that the 
LDL was taken up by macrophages faster than control LDL 
(incubated in the absence of macrophages). This modification 
was likely to be oxidative because macrophages are well known 
to enhance the oxidation of LDL [6,7] and we confirmed this 
by showing enhanced TBARS and electrophoretic mobility in 
these macrophage-modified LDLs. Furthermore, pretreatment 
of the gruel with Chelex-100, which binds transition metal ions, 
could prevent he oxidation of the LDL catalysed by the gruel 
sample. As expected, Chelex-100 removed either copper or iron 
ions that had been added to Ham's F-10 medium and prevented 
them from catalysing LDL oxidation. These observations are 
supported by the work of Smith et al. [17] and Swain and 
Gutteridge [18], who showed that gruel from atherosclerotic 
lesions contained significant levels of catalytically active copper 
and iron ions that were able to catalyse the oxidation of rat liver 
microsomes or linoleic acid micelles. 
The presence of catalytic iron or copper ions in human ad- 
vanced atherosclerotic lesions may explain why LDL becomes 
oxidised in these areas of the body, but does not explain how 
these catalytically active ions become available. There is cir- 
cumstantial evidence to suggest that the interior of atheroscle- 
rotic lesions may be acidic (discussed in [27]). We have shown 
that at acidic pH both caeruloplasmin [10] (the plasma copper- 
carrying protein) and transferrin [28] (the plasma iron-carrying 
protein) can generate catalytically active copper or iron that 
can oxidise LDL. It has also been shown that caeruloplasmin 
can oxidise LDL in phosphate buffered saline [29] and that 
peroxynitrite can make the copper in caeruloplasmin catalyti- 
cally active so that it can catalyse lipid oxidation at pH 7.4 [30]. 
Furthermore, free radical attack on ferritin [31] or haem pro- 
teins [32,33] may release iron ions and in fact oxidised LDL has 
been shown to induce iron release from activated myoglobin 
[34]. 
In conclusion, these studies how that the contents of human 
advanced atherosclerotic lesions contain transition metal ions 
that can support he macrophage-mediated oxi ation of LDL, 
This may help to explain why LDL becomes oxidised in these 
advanced lesions but it does not explain why LDL becomes 
oxidised in early lesions or the normal arterial wall. 
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